author-photo

Reinier O. Schlingemann

University of Amsterdam
University of Lausanne
Netherlands Institute for Neuroscience

218

Papers

11277

Citations

Citation Trend

Filter By

Papers (218) Sort By

Journal Conference Others

Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial

2021 American Journal of Ophthalmology
Show All
- Source
- Cite
- Save
Citations (1)
PDGF as an Important Initiator for Neurite Outgrowth Associated with Fibrovascular Membranes in Proliferative Diabetic Retinopathy.

2021 Current Eye Research
Show All
- Source
- Cite
- Save
Citations (0)
High-salt intake affects retinal vascular tortuosity in healthy males: an exploratory randomized cross-over trial.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro

2021 Cells
Show All
- Source
- Cite
- Save
Citations (3)
Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

2021 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Functional Imaging of the Ocular Fundus Using an 8-Band Retinal Multispectral Imaging System

2020
Show All
- Source
- Cite
- Save
Citations (0)
IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis

2020 Molecular Biology Reports
Show All
- Source
- Cite
- Save
Citations (2)
MicroRNA levels as a biomarker for anti-VEGF response in patients with diabetic macular edema

2020 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Comparing the efficacy of bevacizumab and ranibizumab in patients with retinal vein occlusion: the BRVO study, a randomized trial

2020 Ophthalmology Retina
Show All
- Source
- Cite
- Save
Citations (0)
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

2020 Ophthalmology Retina
Show All
- Source
- Cite
- Save
Citations (3)